CD44 and neoplasm: Ongoing in vitro experiments in our laboratory, aim to identify and validate the molecular players that link the activation of CD44, by its ligand HA, to the transcriptional regulation of PCF11 3’UTR to promote tumor cell invasion and metastasis.